Eli Lilly LLY0.80%increase; green up pointing triangle received approval from the Food and Drug Administration for a label expansion of its weight-loss drug Zepbound, adding a new monthly delivery ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...

Food and Drug Administration Commissioner Marty Makary told CNBC that his view is that "everything should be over the counter" unless a drug is unsafe, addictive or requires monitoring. He said the ...

Feb 17 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Tuesday the European Commission has approved a higher dose of its popular obesity drug Wegovy, providing patients and doctors with an ...

It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful of side effects, mainly along the lines of gastrointestinal issues like nausea and ...

20%-46% of patients with chronic cough, defined as a cough lasting for more than 8 weeks, have RCC, a persistent cough despite thorough investigation and treatment. RCC and its physical and mental ...

Chronic pain is an individual experience with physical and psychological dimensions. Ketamine is used in sub-anesthetic doses to treat chronic pain. We describe a proposed multidisciplinary approach ...

Cartel Expert Becomes First Woman to Lead Nation’s Drug Control Policy Today, in a 52-48 vote, United States Senate confirmed Sara Carter as the 10 th Director of the White House Office of National ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...

Aaron Navarro is a CBS News digital reporter. He covered the 2024 elections and was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. Washington — ...

The Federal Drug Administration said drugmakers have recalled more than 580,000 bottles of a blood pressure medication over concerns that it may include a cancer-causing chemical. New Jersey-based ...